Century Therapeutics
IPSC
IPSC
56 hedge funds and large institutions have $183M invested in Century Therapeutics in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
+4
Holders Change %
+7.69%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
23
Reduced
10
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
+$2.33M |
2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.84M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$733K |
4 |
Millennium Management
New York
|
+$509K |
5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$426K |
Top Sellers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$5.48M |
2 |
OCA
Octagon Capital Advisors
New York
|
-$3.35M |
3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$1.32M |
4 |
LGM
Logos Global Management
San Francisco,
California
|
-$619K |
5 |
D.E. Shaw & Co
New York
|
-$282K |